Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
103.22
+1.40 (1.37%)
Aug 13, 2025, 4:00 PM - Market closed
Zimmer Biomet Holdings Market Cap
Zimmer Biomet Holdings has a market cap or net worth of $20.45 billion as of August 14, 2025. Its market cap has decreased by -10.29% in one year.
Market Cap
20.45B
Enterprise Value
27.61B
1-Year Change
-10.29%
Ranking
Category
Stock Price
$103.22
Market Cap Chart
Since July 25, 2001, Zimmer Biomet Holdings's market cap has increased from $5.76B to $20.45B, an increase of 254.87%. That is a compound annual growth rate of 5.40%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 20.45B | -2.76% |
Dec 31, 2024 | 21.03B | -17.32% |
Dec 29, 2023 | 25.43B | -4.95% |
Dec 30, 2022 | 26.76B | 0.82% |
Dec 31, 2021 | 26.54B | -16.91% |
Dec 31, 2020 | 31.94B | 3.74% |
Dec 31, 2019 | 30.79B | 45.52% |
Dec 31, 2018 | 21.16B | -13.41% |
Dec 29, 2017 | 24.43B | 18.20% |
Dec 30, 2016 | 20.67B | -1.12% |
Dec 31, 2015 | 20.91B | 8.84% |
Dec 31, 2014 | 19.21B | 20.55% |
Dec 31, 2013 | 15.93B | 37.77% |
Dec 31, 2012 | 11.57B | 20.83% |
Dec 30, 2011 | 9.57B | -9.69% |
Dec 31, 2010 | 10.60B | -15.81% |
Dec 31, 2009 | 12.59B | 38.69% |
Dec 31, 2008 | 9.08B | -41.54% |
Dec 31, 2007 | 15.53B | -16.99% |
Dec 29, 2006 | 18.71B | 11.94% |
Dec 30, 2005 | 16.71B | -14.98% |
Dec 31, 2004 | 19.65B | 15.44% |
Dec 31, 2003 | 17.02B | 110.23% |
Dec 31, 2002 | 8.10B | 36.81% |
Dec 31, 2001 | 5.92B | 2.73% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 571.23B |
Johnson & Johnson | 419.15B |
AbbVie | 349.50B |
Abbott Laboratories | 229.58B |
UnitedHealth Group | 229.23B |
Novartis AG | 228.69B |
AstraZeneca | 227.85B |
Novo Nordisk | 222.88B |